Mapping Alzheimer's
LOS ANGELES (Ivanhoe Newswire) -- Though there’s no
cure for Alzheimer's disease, the earlier it’s
diagnosed, the more effectively it can be treated. The
problem is there’s never been a conclusive way to
diagnose the disease’s progression … until now.
It took dedicated researchers, and a super computer,
to produce this seven-second video image. What it
reveals may change the future of Alzheimer's
disease.
“You actually get a physical picture of how the
devastation of Alzheimer's is spreading across the
brain, which parts of the brain are affected, and how
fast,” says Paul Thompson, Ph.D., Assistant Professor of Neurology
at the University of California, Los Angeles.
The sequence is actually a composite of a dozen
patients who had MRIs over a year and a half. This
computer combined the brain scans into a moving image.
The red areas show brain cells dying.
Thompson says: "Memory
areas lose tissue first. That makes sense because memory
is the first to go. Then the emotional areas of the
brain, and the areas involved in self control, are the next
to go.”
For people like Ray Averill, the new technology could
buy time. He's showing early signs of what may be
Alzheimer's. “Verbally when I want to talk, I will have
difficulty getting the right word out. Though I know
what the word is, my mouth won’t say the right thing,”
he says.
If Averill does have
early Alzheimer's disease, the new technology could help
get him the treatment he’ll need to slow the
progression. “They’ll be able to make the change and
say, ‘Oh, this isn’t gonna be able to work on him. See
what’s happened here. Now we’ll try this one,'” says
Averill.
Researchers say that may now be possible, thanks to
these images that are catching Alzheimer's
red-handed.
Alzheimer’s disease kills off brain cells at a rate
of 5 percent to 10 percent a year. As many as 7 million
Americans have the disease.
This article was reported by Ivanhoe.com, who offers
Medical Alerts by e-mail every day of the week. To
subscribe, go to: http://www.ivanhoe.com/newsalert/.
If you would like more information, please
contact:
UCLA Alzheimer's Disease Research Center
710
Westwood Plaza, Room 2238
Los Angeles, CA
90095-1769
(310) 206-5238
adc@ucla.edu
Paul Thompson, Ph.D.
University of California,
Los Angeles
David Geffen School of Medicine
4328
Reed Neurology
710 Westwood Plaza
Los Angeles,
CA 90095-1769
thompson@loni.ucla.edu
http://www.loni.ucla.edu/~thompson/thompson.html